Q3 2024 Biotage AB Earnings Call Transcript
Afternoon, everyone depending where you are joining us today for the bio dash 2,324 earning calls.
My name is Frederic Van Der Egen, CEO of Bioa.
I've joined the company a little more than six weeks ago and I'm thrilled to share with you our solid Q 3 2024 results. Joining me today on the call is Andrew cat, our CFO this is the agenda for the call today.
After a short summary of who we are as a company, I will provide the highlights for the Q3 results and Andrew will secondly, in detailing those.
I'm thrilled to join the company as Bioag is a very resilient business model. It does equipment services and consumable that addresses the sample preparation challenges across multiple markets from applied markets such as forensic food and environmental. All the way to drug discovery and development for the BioPharma industry.
In that particular market. We have solution from discovery all the way up to downstream processing.
Bioag has continued to evolve its portfolio to capture market opportunities
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
Trustpilot
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
